Bayhealth Medical Center is a healthcare system serving the central and southern portion of Delaware in the United States.

There are 316 beds in Bayhealth Hospital Kent Campus.

During the past decade, Bayhealth Hospital Kent Campus conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 18 clinical trials were completed, i.e. on average, 94.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 10 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bayhealth Hospital Kent Campus" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bayhealth Hospital Kent Campus" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Bayhealth Hospital Kent Campus" are "Breast Cancer" (6 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials), "Stage IVB Lung Cancer AJCC v8" (6 trials) and "Recurrent Breast Carcinoma" (5 trials). Many other conditions were trialed in "Bayhealth Hospital Kent Campus" in a lesser frequency.

Most popular intervention types in "Bayhealth Hospital Kent Campus" are "Drug" (39 trials), "Other" (24 trials), "Biological" (16 trials), "Procedure" (5 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (15 trials), "Quality-of-Life Assessment" (10 trials), "Paclitaxel" (7 trials), "Bevacizumab" (6 trials) and "Docetaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Bayhealth Hospital Kent Campus" are 30 trials for "All" genders, 10 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Bayhealth Hospital Kent Campus". undefined are not yet recruiting, 9 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Bayhealth Hospital Kent Campus, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Bayhealth Hospital Kent Campus, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".